the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

HP projects downbeat Q1 profit amid slow PC market recovery

PALO ALTO: HP Inc on Tuesday (Nov 21) forecast first-quarter profit below Wall Street estimates but maintained its annual earnings outlook, a sign that demand in the personal computers market is still recovering.

Companies such as HP, Lenovo and Dell Technologies have seen demand ease from peaks hit during the pandemic, when work-from-home trends drove up sales of laptops and other electronic devices.

HP expects first-quarter adjusted profit per share to be in the range of 76 cents to 86 cents, the midpoint of which was lower than analysts’ average estimate of 86 cents, according to LSEG data.

Shares of the Palo Alto, California-based company were down more than 4% after the bell.

The company said it is on track to launch its AI PCs in the second half of next year and expects its penetration to increase gradually.

“Don’t think the market will immediately shift to AI PCs, we think there will be some penetration in ‘24 and stronger in ‘25,” chief executive Enrique Lores said in a media call.

Recent earnings at major PC chipmakers, including Intel and Advanced Micro Devices, have also signaled that more than a two-year long slump in the market could be nearing an end as demand picks up ahead of the holiday season and an expected Windows update next year from Microsoft.

Its revenue for the fourth quarter stood at US$13.82 billion (RM64.27 billion), slightly lower than LSEG estimates of US$13.85 billion.

HP maintained its fiscal 2024 adjusted profit forecast range of US$3.25 to US$3.65 per share.

“Continue to see weak demand in China both across consumer and commercial and at this point we don’t expect that to change,” Lores said.

Sales for HP’s personal systems segment – home to its desktop and notebook PCs – fell 8% from a year ago, while its printing segment posted a 3% fall. – Reuters

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings